Company: PSTV
Filing Date: 2025-07-11
Form Type: PRE 14A
Source: 0001140361-25-025650
Chunk: 77

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-11
Form: PRE 14A
Chunk 77
---
ISOs”) has been increased to 21,303,334 shares. |

| • | The Fifth Amended Plan extends the period during which ISOs can be granted—up until ten (10) years following the date the Fifth Amended Plan was approved by the Board. |

The following summary of the principal features of the Fifth Amended Plan is qualified in its entirety by the full text of the Fifth Amended Plan, a copy of which is attached to this Proxy Statement as Appendix B. Compensation and Governance Best Practices The Fifth Amended Plan, approved by our Board and submitted for stockholder approval, includes an increase in the number of shares available for issuance of equity incentive awards by the Company by 20,000,000 shares. The Fifth Amended Plan contains the following important compensation and governance best practices:

| • | No single trigger accelerated vesting upon change in control. The Fifth Amended Plan does not provide for automatic vesting of awards upon a change in control. |

| • | No liberal change in control definition. The change in control definition in the Fifth Amended Plan is not a “liberal” definition. A change in control transaction must actually occur in order for the change in control provisions in the Fifth Amended Plan to be triggered. |

| • | No discounted stock options or stock appreciation rights. All stock options and stock appreciation rights granted under the Fifth Amended Plan must have an exercise or strike price equal to or greater than the fair market value of a share of our Common Stock on the date the stock option or stock appreciation right is granted. |

| • | Administration by independent committee. The Fifth Amended Plan will be administered by the members of the Compensation Committee, all of whom are “non-employee directors” within the meaning of Rule 16b-3 under the Exchange Act and are “independent” within the meaning of the Nasdaq listing standards. |

50

TABLE OF CONTENTS

| • | Material amendments require stockholder approval. Consistent with Nasdaq rules and regulations, the Fifth Amended Plan requires stockholder approval of any material revisions to the Fifth Amended Plan. In addition, certain other amendments to the Fifth Amended Plan require stockholder approval. |

| • | Repricing not permitted. Repricing of stock options or stock appreciation rights and the cancellation of stock options or stock appreciation rights with an exercise price greater than the current fair market value of a share in return for cash or the grant of new stock options or stock appreciation rights with a lower exercise price or the grant